A Phase 2, Open-label, Single-arm, Efficacy and Safety Study of Enzalutamide (MDV3100) in Patients With Hormone-naïve Prostate Cancer

Name: A Phase 2, Open-label, Single-arm, Efficacy and Safety Study of Enzalutamide (MDV3100) in Patients With Hormone-naïve Prostate Cancer
Creator: Vivli
Published: 2025-06-01 01:05:36
License: 暂无描述

DataCite Commons2025-06-01 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/PR00010649/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

To evaluate the effect of enzalutamide on prostate specific antigen (PSA) level in men with prostate cancer.

提供机构：

Vivli

创建时间：

2024-10-10